#ESC20 PARALLAX Trial 🧵 -2,566 HF patients (LVEF >40%) -Sacubitril-Valsartan vs Active-controlled treatment (Enalapril, Valsartan or Placebo)

#ESC20 PARALLAX Trial 🧵 -2,566 HF patients (LVEF >40%) -Sacubitril-Valsartan vs Active-controlled treatment (Enalapril, Valsartan or Placebo)